Skip to content
★ Sign in to follow
RM

Richard M. Johnston

Executive
AtriCure, Inc.Echo Healthcare Acquisition Corp.
Total declarations
74
Companies
2
▲ Purchases (2 ops.)
€817k
▼ Sales (42 ops.)
€2.9M

Latest filing published 25 May 2017 for AtriCure, Inc..

Insider track record

Disclosed buys
2
Disclosed sells
42
Signal history

No signal scores available.

Closed purchases

Market purchases
2
Positive at T+90
0%
Median T+90
-17.8%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 06 Feb 2008 · 6850 days ago · €772k
    -88.7%
    Entry US$13.68 · Close at T+365 US$1.54

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Richard M. Johnston: trading record in brief

This profile gathers the share dealings of Richard M. Johnston across 2 companies, led by AtriCure, Inc. and Echo Healthcare Acquisition Corp. The record holds 74 filings, for trades running from 30 May 2007 to 24 May 2017.

On the open market, the record shows 2 purchases worth €817k and 42 sales worth €2.9M. Netting one side against the other leaves €2.1M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 6 share grants and 13 option exercises.

Most recently, on 25 May 2017, the filings show a share grant in AtriCure, Inc. The last purchase on record was published on 6 February 2008, which is 6,850 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Richard M. Johnston

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations74 total

25 of 74 declarations